Physician profile
Michael J Franklin
NPI 1487624078
$5,166.18
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $248 · 2021: $1,055 · 2022: $1,246 · 2023: $1,404 · 2024: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.59 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $1,330.55 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $1,251.32 | 2019-2024 | Dupixent |
| Genzyme Corporation | $730.25 | 2021-2024 | |
| Glaxosmithkline, LLC. | $697.44 | 2021-2024 | Nucala |
| Intersect Ent, INC. | $696.49 | 2019-2022 | |
| Medtronic, INC. | $134.78 | 2023 | Sinuva |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Stryker Corporation | $72.18 | 2021-2023 | Audion Et Dilation System |
| Alk-Abello, INC | $57.69 | 2020-2021 | |
| Greer Laboratories, INC. | $33.33 | 2019 | |
| Inspire Medical Systems, INC. | $31.96 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $19.74 | 2021 | |
| Acclarent, INC | $15.58 | 2019 | |
| Hikma Pharmaceuticals USA | $14.88 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.